Focus on ROI sharpens as value-based care adoption slows

With growth sluggish in the adoption of value-based care reimbursement, the healthcare industry in the United States has zeroed in on a strategic, risk-adverse approach that demonstrates a strong return on investment (ROI), according to a new report from KLAS and College of Healthcare Information Management Executives (CHIME).

The new Decision Insights report is based on findings from KLAS Decision Insights, the KLAS 2019 Population Health Management Cornerstone Summit, and CHIME’s 2019 HealthCare’s Most Wired data.

“Digital Health Most Wired shows how industry-leading healthcare organizations are using data and analytical tools to support population health strategies and progress in their digital health strategies,” said Russell Branzell, CHIME’s president and CEO.

“Providers are trying to find positive ROI on their population health management investments,” said Adam Gale, president of KLAS Research. “This report offers a useful roadmap for how they can meet that challenge.”

Among the findings:

  • Fee-for-service still outpaces value-based reimbursement, and over time, the lack of significant progress has eroded confidence that the change will happen in the near future.
  • Electronic medical records (EMRs) are not often chosen for specific population health management needs, but provider organizations almost always consider them first.
  • Organizations invest in HIT when there is a concrete ROI and solutions that help organizations identify and act on care gaps.

To read more or see the full report, click here.

Posted by Jana Ballinger 11/19/2020 Categories: Health IT Value-Based Care